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Abstract
Background: Subacromial impingement syndrome (SIS) is a painful, and often long lasting, shoulder condition
affecting patient function and quality of life. In a recent study, we observed major strength impairments in shoulder
external rotation and abduction (~30%) in a population of patients with pronounced and long-lasting SIS. However,
the current rehabilitation of such strength impairments may be inadequate, with novel rehabilitation programmes
including exercise therapy only improving external rotation strength by 4–13%.
As these previous studies are the basis of current practice, this suggests that the strengthening component could
be inadequate in the rehabilitation of these patients, and it seems likely that more emphasis should be placed on
intensifying this part of the rehabilitation.
The purpose of this study is to investigate the effectiveness of a programme consisting of progressive home-based
resistance training using an elastic band, aimed at improving shoulder external rotation and abduction strength,
added to usual care and initiated shortly after diagnosis has been established.
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Methods: A pragmatic randomised controlled superiority trial will be conducted, including 200 patients with
pronounced and long-lasting SIS, diagnosed using predefined criteria. Participants will be randomised to receive
either an add-on intervention of progressive home-based resistance training using an elastic band in addition to
usual care or usual care alone in a 1:1 allocation ratio. The randomisation sequence is computer generated, with
permuted blocks of random sizes. The primary outcome will be change in Shoulder Pain And Disability Index
(SPADI) score from baseline to 16 weeks follow-up. Outcome assessors are blinded to group allocation. Intervention
receivers will be kept blind to treatment allocation through minimal information about the content of the add-on
intervention and control condition until group allocation is final. Analyses are performed by blinded data analysts.
Discussion: If effective, the simple shoulder strengthening exercise programme investigated in this trial could easily
be added to usual care. The usefulness of the trial is further supported by the magnitude of the problem, the
information gained from the study and the pragmatism, patient centeredness and transparency of the trial.
Trial registration: The trial is pre-registered at ClinicalTrials.gov with the ID NCT02747251 on April 19, 2016.
Keywords: Shoulder, Impingement, Pragmatic, Strength, Progressive, Exercise, RCT, Rotator cuff, Adherence,
Sensitisation
Background
Shoulder disorders are the second most frequent musculo-
skeletal reason for contacting a general practitioner [1].
Nearly half of these incidents are categorised as subacromial
impingement syndrome (SIS) [2], a painful, and often long
lasting [3], condition affecting patient function and quality of
life [4]. In Denmark, the incidence of SIS reported in primary
care is approximately 8 per 1000 inhabitants per year [5].
Further, with an average yearly cost per incident case of
shoulder disorder of €4000 [6], as reported in Sweden, the
societal costs related to SIS are noteworthy. However, most
of the costs (74%) are related to a sub-group of patients
(12%) with high pain intensity and more pronounced and
long-lasting disability [7]. In this sub-group, sick leave from
paid work accounts for more than half (61%) of the costs [7].
The latest systematic review on the efficacy of exercise
therapy in the treatment of SIS suggests that an exercise
intervention improves patient-reported function and pain in
patients with long-lasting SIS (≥ 3 months), to a degree
equivalent to surgery followed by post-operative rehabilita-
tion [8]. In addition, an intervention including specific exer-
cises significantly reduced the amount of operations in
patients on the waiting list for surgery for SIS [9]. Consistent
with these studies, the Danish national clinical guidelines for
treatment of SIS recommends an exercise intervention last-
ing at least 3 months [10]. However, it is unknown which
specific components of the heterogeneous exercise interven-
tions are associated with a better outcome [11] and, though
not demonstrated in patients with long-lasting SIS, patient
adherence to the prescribed exercise interventions is also
likely to moderate the effects of such interventions.
Mechanisms
Resistance training, aimed at strengthening the rotator
cuff muscles and scapula stabilising muscles, is an
important component of most novel exercise interven-
tions for long-lasting SIS [9, 12, 13]. This seems relevant
as patients with SIS have significant force impairments
in both the glenohumeral and the scapulothoracic joint
[4, 14, 15]. However, these force impairments are most
pronounced in the glenohumeral joint, with a 33% def-
icit in external rotation force and a 29% deficit in abduc-
tion force compared to only 8% and 18% force deficit in
protraction and retraction of the scapula, respectively
[15]. This suggests that specific training of the gleno-
humeral muscles is especially relevant. Such specific re-
sistance training of the, often degenerated [16], rotator
cuff muscles and tendons also seems relevant as this
training modality is known to improve muscle and ten-
don health through various pathways [17].
Need for a trial
It is uncertain if the novel exercise intervention pro-
grammes, aimed at patients with long-lasting SIS, are focus-
ing sufficiently on strengthening exercises. Accordingly,
changes in muscle force are only tested in a few rando-
mised controlled trials (RCTs), including resistance training
in the rehabilitation of patients with SIS [12, 13, 18, 19]. In
these studies, maximum force in external rotation increased
by only 4–15% in average from baseline to follow-up in pa-
tients doing strengthening exercises [12, 13, 18, 19], which
is far from restoring the 33% impairment in external rota-
tion force previously reported [15]. Though strength gain
may not be the primary aim of the intervention, the sparse
effect on this objective outcome points towards a possible
gap in the rehabilitation of patients with long-lasting SIS.
This suggests that the exercise dose received by patients
might have been too small, either because the prescribed
resistance training programmes were too mild, or simply
due to lack of adherence to the prescribed programmes.
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The trial described in this protocol will aim to investigate
the effectiveness of adding a simple shoulder strengthening
exercise programme to usual care in patients with long-
lasting SIS.
Existing knowledge
To further ensure that we do not initiate a redundant
trial, we have performed a systematic literature review.
On January 26, 2016, we performed a systematic litera-
ture search on controlled trials investigating the effect of
resistance training in patients with SIS. We searched
Medline via PubMed (86 hits) and Embase via OVID (38
hits) using search strings for condition (shoulder im-
pingement) and intervention (resistance training). We
also searched www.clinicaltrials.gov for registered (fina-
lised, ongoing or planned) trials. We only identified one
trial [18] in which the effect of resistance training was
isolated as the active part of the intervention. Addition-
ally, in a recent systematic review, only one study [20]
investigating the effect of an exercise intervention in pa-
tients with persistent SIS was identified, and in that
study the exercise intervention was compared to surgery.
In conclusion, the existing evidence regarding the effect
of resistance training in patients with persistent SIS is
very limited and we therefore consider this to provide a
clear-cut ethical, scientific and economic justification for
the trial described in this protocol.
Dose selection
As previously stated, the exercise dose received by pa-
tients might have been too small in previous studies, ei-
ther because the prescribed resistance training
programmes were too mild or simply due to lack of ad-
herence to the prescribed programmes. In the study by
Lombardi et al. [18], patients allocated to an interven-
tion consisting of supervised strengthening exercises
only increased 9% in external rotation strength (derived
from Lombardi et al. [18]), which was not significantly
different from the waiting list control group. As exercise
sessions were supervised, this absence of effect is likely a
consequence of the prescribed dose being too small,
with exercises for flexion, extension, internal and exter-
nal rotation performed twice a week in 8 weeks with 2 ×
8 repetitions at 50% and 70% of 6RM, respectively. One
way to efficiently increase the exercise dose in rehabilita-
tion is to include home-based exercises, as was done in
a study by Bennell et al. [12]. In that study, an interven-
tion consisting of manual therapy and home exercises
was found superior to placebo in improving abduction
strength (significant 15% increase), but not external rota-
tion strength (non-significant 4% increase), pain scores
or patient-reported function at the end of treatment.
The limited gains in shoulder strength observed in the
study by Bennell et al. [12] might also be a consequence
of an insufficient exercise dose received by the patients.
However, it is difficult to determine whether the sparse
improvements in shoulder strength are due to the
programme being too mild or because of low adherence,
as the amount of external resistance applied to exercises
is not described. Nevertheless, exclusion of non-
adherent patients from the analyses did not alter the re-
sults, indicating that the sparse improvements in shoul-
der strength were not only due to low adherence.
In the current study, we aim to increase the received dose
of strengthening exercises aimed at the rotator cuff muscles
in patients with long-lasting SIS without aggravating their
symptoms and with minimal risk of adverse events. To
achieve this, the intervention will start with exercises using
low relative resistance but high volume (number of sets per
session and frequency of sessions). This approach is also
relevant, as resistance training with low intensity/resistance,
high frequency and approximately 3–4 sets per muscle
group is associated with the highest gains in muscle
strength in untrained individuals [21]. All sets are to be
continued to failure, as this maximises the gain in local
muscle endurance [22]. Furthermore, the low resistance will
minimise pain during exercises and protect the muscle
from overload injuries, ensuring that all patients are able to
complete the programme.
The focus of exercises is on isometric holds and slow
dynamic strengthening with a long time under tension
(TUT). A high TUT is achieved through exercises with a
low contraction velocity and the inclusion of an isomet-
ric component to increase the exercise stimulus without
increasing external resistance; this in turn reduces the
peak load on the involved, and possibly damaged [16],
muscles and tendons. Thus, exercises become safer and
less painful, which again will allow patients to actually
adhere to the exercise intervention. Furthermore, the
isometric part will be performed with the shoulder in
approximately 30–45 degrees of scaption, the position in
which the compression forces on the supraspinatus
muscle and tendon are lowest [23, 24]. Exercises will
mainly focus on external rotation and abduction, func-
tions in which both supraspinatus and infraspinatus
muscles are highly active [25].
Possible effect modifiers
Patients with long-lasting SIS have lower mechanical
pressure pain thresholds (PPT), both at the shoulder re-
gion and in other anatomical regions (such as the tibialis
anterior), which may reflect an increased manifestation
of peripheral and central pain sensitisation [26]. Pain
sensitisation modulates the patients’ pain experience
and, furthermore, the presence of hyperalgesia or re-
ferred pain before decompression surgery significantly
worsens the outcome after 3 months [26], while more
pain catastrophizing is related to persistence of
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symptoms in patients with long-lasting SIS [27]. It there-
fore seems likely that manifestations of peripheral and
central pain sensitisation, and peripheral adaptations to
long-lasting pain, could also affect the outcome of an ex-
ercise intervention. This could be either through an al-
teration in adherence to the intervention due to pain
sensitisation, or through other mechanisms related to
central pain sensitisation and peripheral adaptations.
The effect of scapula function on treatment outcome in
patients with SIS is often debated, and one could argue that
the increased emphasis on rotator cuff muscles, as is pro-
posed in the current trial, would neglect an important as-
pect of the rehabilitation. Accordingly, it has been
suggested that rotator cuff emphasis should only be after
scapula control is achieved, as insufficient dynamic stability
of the scapula could cause abnormal shoulder kinematics
and impingement symptoms [28]. Assuming this, the effect
of the add-on intervention in the current study, focusing
mainly on strengthening exercises for the rotator cuff, could
be modified be the presence of scapula dyskinesis. However,
Mulligan et al. [29] recently found that treatment outcome
was not significantly different between patients randomised
to scapula stabilisation first, or rotator cuff strengthening
first, questioning the importance of maintaining a scapula
focus in the beginning of rehabilitation.
Explanation for choice of comparators
This study aims to investigate the effectiveness of adding
a simple shoulder strengthening exercise programme to
usual care in patients with long-lasting SIS. Therefore,
the relevant control condition is usual care, which is to
be compared to the intervention condition involving an
add-on exercise programme and usual care.
This is relevant because usual care for patients that are
covered by the Danish National Guidelines for Treatment
of SIS [10], and hence have a medically justified need for
general rehabilitation, is referral to general rehabilitation
under the Danish health act § 140. Such rehabilitation is
likely based on the most novel evidence from previously
mentioned RCTs [12, 13, 18], where only limited gains in
muscle strength are found. It therefore seems unlikely that
the current treatment addresses the issue of glenohumeral
muscle strength to a sufficient degree.
Furthermore, direct monitoring of adherence to the
add-on intervention makes it possible to conduct sec-
ondary analysis, investigating the relationship between
exercise adherence and changes in both strength and
patient-reported function.
Methods
Objectives
Primary research question
Based on the literature reviewed in the “Background”
section, we asked the following research question:
Is a 16-week simple home-based shoulder strengthen-
ing exercise programme, in addition to usual care, super-
ior to usual care alone for improving patient-reported
shoulder function 16 weeks after baseline, measured
using the Shoulder Pain And Disability Index (SPADI),
in patients with persistent (> 3 months) subacromial im-
pingement syndrome referred to further examination at
a hospital?
The research question was framed using the PICOT
model [30] with the following options for each element:
Population: Patients with persistent SIS (> 3 months)
Intervention: 16-week simple home-based shoulder
strengthening exercise programme added to usual care
Control: Usual care
Outcome: Patient-reported shoulder function
Time frame: 16 weeks after baseline
Primary objective
The primary objective is therefore to investigate the ef-
fectiveness of adding a 16-week simple home-based
shoulder strengthening exercise programme to usual
care, compared to usual care alone, on changes in
patient-reported shoulder function (SPADI score) from
baseline to end of treatment (16 weeks) in patients with
SIS.
Primary research hypothesis
Our hypothesis is that a 16-week simple home-based
shoulder strengthening exercise programme, in addition
to usual care, is superior to usual care alone for improv-
ing patient-reported shoulder function 16 weeks after
baseline, measured using the SPADI, in patients with
persistent (> 3 months) subacromial impingement syn-
drome referred to further examination at a hospital.
Secondary objectives
1. To investigate the effectiveness of adding a 16-week
simple home-based shoulder strengthening exercise
programme to usual care, compared to usual care
alone, on changes in shoulder abduction and exter-
nal rotation strength from baseline to end of treat-
ment (16 weeks) in patients with SIS.
2. To investigate the modifying effects of pain
sensitisation, pain catastrophizing and scapula
function on the effectiveness of adding a 16-week
simple home-based shoulder strengthening exercise
programme to usual care, compared to usual care
alone, on changes in patient-reported shoulder func-
tion and shoulder abduction and external rotation
strength from baseline to end of treatment (16
weeks) in patients with SIS.
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3. To investigate the dose-response relationship be-
tween objectively monitored adherence to the add-
on intervention and change in patient-reported
shoulder function, shoulder abduction strength and
external rotation strength.
4. To investigate the relationship between central and
peripheral pain sensitisation and change in patient-
reported shoulder function, shoulder abduction
strength and external rotation strength, and to what
degree this is mediated through adherence to the
intervention.
Trial design
The SExSI-Trial is a pragmatic, assessor blinded, rando-
mised, controlled superiority trial, with a two-group par-
allel design. Patients will be randomised to either usual
care or a home-based intervention consisting of progres-
sive high volume resistance training in addition to usual
care with a 1:1 allocation. The primary end-point will be
change in patient-reported shoulder function 16 weeks
after baseline.
This clinical trial protocol is based on the PREPARE
Trial guide [31] and the SPIRIT checklist [32] (Add-
itional file 1). The trial report will adhere to the CON-
SORT guidelines for reporting parallel group
randomised trials, the CONSORT extension for prag-
matic trials http://www.consort-statement.org, and the
TIDieR template for intervention description and repli-
cation [33].
Study setting and eligibility criteria
Participants will be recruited from the secondary care
orthopaedic outpatient clinic at Hvidovre Hospital. Con-
secutive sampling will be used to ensure generalisability
of the results. Accordingly, all patients who are referred
for the first time to the clinic for examination of their
current shoulder disorder lasting at least 3 months, who
are living in the Capitol Region of Copenhagen,
Denmark, who are not pregnant, do not permanently
use strong pain medication (defined as morphine anal-
gesic or similar), are aged 18–65 and are considered able
to understand spoken and written Danish will be evalu-
ated for eligibility by an orthopaedic specialist. All eli-
gible patients will be provided with written information
about the study.
Patients will be invited to participate if they meet
the following inclusion criteria: (1) At least three positive
of the five diagnostic tests for subacromial impingement
syndrome (Hawkins-Kennedy test, Neer’s test, pain-full
arc, Resisted External Rotation test and Jobe’s test) [34];
(2) Have been provided with or offered a rehabilitation
plan due to a medically justified need for general re-
habilitation after discharge from the hospital under the
Danish Health Act § 140; and (3) hand in a completed
SPADI questionnaire on the day of the medical
examination.
Patients will be excluded if they fulfil any of the exclusion
criteria, namely (1) have a radiologically verified new or
previous fracture related to the shoulder joint, including the
scapula; (2) have radiologically verified glenohumeral
osteoarthritis; (3) have a clinically suspected luxation or sub-
luxation of the glenohumeral, acromioclavicular or sternocla-
vicular joint; or (4) have a clinically suspected labral lesion,
complete traumatic tear of the rotator cuff, frozen shoulder
or other competing diagnoses (i.e. rheumatoid arthritis, can-
cer, neurological disorders, fibromyalgia, psychiatric illness).
Interventions
Both groups will receive usual care consisting of an offer
of referral to general rehabilitation in the municipal clinic
under the Danish health Act § 140, sometimes with the
option to instead choose a private physiotherapy clinic,
partly at their own expense. The referral is standard pro-
cedure when a patient with SIS is considered to have a
medically justified need for general rehabilitation, as iden-
tified during the examination at the orthopaedic out-
patient department (secondary care unit). This procedure
is based on the Danish National clinical guideline on diag-
nostics and treatment of patients with selected shoulder
disorders [10], as exercise therapy is recommended as first
line of treatment for SIS.
In the context of this study, usual care includes all
treatment received by a patient during the time between
baseline and follow-up, except that included in
‘Strengthen your Shoulder’. Therefore, usual care might
include a range of treatment modalities including advice,
stretching, exercises, manual therapy, massage, acupunc-
ture and electrotherapy at the discretion of the treating
physiotherapist and doctor. A description of usual care
following the TIDieR guidelines [33] is included in
Additional file 2.
Patients in the intervention group will, in addition to
usual care, receive instructions regarding a home-based,
progressive, high volume resistance-training programme
immediately after randomisation. Instructions in the ex-
ercises are provided at baseline (week 0) and after 2, 5,
10 and 16 weeks. The exercise programme has been de-
veloped in cooperation with a team of experts with ex-
tensive knowledge of both exercise physiology and
rehabilitation and training of patients with shoulder dis-
orders (MC, TB, KT and MR). The design of the exer-
cises, and their progression, is based on the relevant
literature regarding exercise physiology, shoulder
biomechanics and strength training principles for
both healthy people and patients with shoulder dis-
orders. A standard protocol for individual adaptation
of the programme based on pain response is part of
the intervention.
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A thorough description of the intervention, and modi-
fications of the intervention, following the TIDieR guide-
lines [33], is included in Additional file 3, and the full
set of strength training descriptors, as suggested by
Toigo and Boutellier [35], are presented in Table 1. An
online instruction video of the exercises will be made
available upon publication of the main results of the
trial, and a link to these is provided in Additional file 3.
Interventions – adherence
Lack of adherence to an exercise intervention is a major
problem when aiming at investigating the effect of an
intervention. In the previously described studies that in-
clude unsupervised resistance training in rehabilitation
of SIS patients, monitoring adherence is either done
using a log-book filled in by the patients [9, 12] or not
described at all [13]. Using only patient-reported mea-
sures of adherence may limit the possibility of detecting
which exercise dose is actually received by the patient.
Accordingly, in a recent systematic review, the authors
did not identify a single measure of patient-reported ad-
herence to unsupervised home-based rehabilitation
exercises to be sufficiently investigated [36]. Further-
more, findings from one previous study revealed that the
dose of exercises reported in exercise diaries were 2.3
times higher than that collected through a system which
monitored the exact TUT, being the total time a muscle
resists weight during each set [37]. This clearly under-
lines the relevance of collecting objective data on exer-
cise adherence. In addition, it seems unlikely that
patients are always able to ‘take’ precisely the exercise
dose prescribed. This issue was unfolded in a recent
study, revealing that, just 2 weeks after initial instruc-
tions, only 7 out of 29 young healthy individuals were
able to use the correct TUT, when performing shoulder
exercises with an elastic band [38].
In the SExSI-Trial, adherence to the add-on progres-
sive high volume resistance training intervention will be
captured using the BandCizer©. The BandCizer© is a
small device which is mounted on the elastic band dur-
ing exercises to measure the TUT, number of repetitions
and total work load for all exercises performed. Exactly
TUT is a promising objective measure of exercise adher-
ence, for which the BandCizer© is specifically developed
and validated [39–41]. By directly monitoring the actual
TUT for the prescribed exercises a more precise and ob-
jective distinction between adherent and less adherent
patients will be possible.
In both the intervention group and the control group,
the time spent on exercises related to usual care will be
monitored by self-report, using a text-message based
system (SMS-track©). Each week all participants will re-
ceive a text-message question regarding the time spent
on exercises performed for their shoulder disorder. Par-
ticipants in the intervention group will be instructed not
to include the time spent on the add-on intervention in
this report.
In the intervention group, face-to-face adherence re-
minders will be given by the investigator administering
the intervention at the initial intervention instruction
and at each subsequent intervention appointment (week
0, 2, 5, 10 and 16). The reminders will focus on (1) the
importance of performing all prescribed exercises and
on correct execution of exercises; (2) emphasising that
the intervention is an add-on to usual care, and should
not be a substitution for this; and (3) counteracting im-
portant barriers to ongoing engagement with home exer-
cises, as identified by Littlewood et al. [42], namely the
simplicity of the intervention (lack of potential effective-
ness), lack of an early appreciable symptom response,
when symptoms are reduced to a certain point, and a
lack of self-efficacy.
Intervention adherence will further be enhanced by
supplying a leaflet with the programme to stick on the
fridge, and via the proactive follow-up intervention ap-
pointments, aspects known to improve patients
Table 1 Strength training descriptors [35] of the exercises
performed in the intervention group
Phase 1 Phase 2 Phase 3
Load magnitude 15–20 RM 10–15 RM 8–10 RM
Number of repetitions To volitional
muscular
fatigue
To volitional
muscular
fatigue
To volitional
muscular
fatigue
Number of sets 3 sets 4 sets (2 per
exercise)
6 sets (2 per
exercise)
Rest in-between sets 60 s 60 s 60 s
Sessions per week 7 per week 3.5 per week 3.5 per week
Duration of
experimental period
5 weeks 5 weeks 6 weeks
Contraction modes per
rep
Concentric 2 s 2 s 2 s
Isometric 5 s 5 s 5 s
Eccentric 2 s 2 s 2 s
Rest between reps 2 s 2 s 2 s
Time under tension 9 s 9 s 9 s
Volitional muscular
fatigue
Yes Yes Yes
Rest between sessions 24 h 48 h 48 h
Anatomical definition
of exercise
Yes Yes Yes
Range of movement Exercise 1:
80° ER
Exercise 1:
80° ER
Exercise 2:
45° ABD
Exercise 1:
80° ER
Exercise 2:
45° ABD
Exercise 3:
45° ER
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adherence to a home-based exercise programme [42].
For an English version of the leaflets, see Add-
itional files 4, 5 and 6.
Interventions – concomitant care
Concomitant use of corticosteroid injections will be
based on the treating orthopaedic specialist’s evaluation,
which is in accordance to the departments standard pro-
cedure and in line with the Danish national guidelines
for treatment of SIS [10]. For pain relief, concomitant
use of orally suspended NSAIDs will be permitted at pa-
tients’ own discretion. Corticosteroid injections and use
of pain medication will be recorded.
Outcomes
Primary outcome
The primary outcome will be the change in the patient-
reported outcome (PRO) score SPADI [43]. SPADI is a
widely used shoulder-specific PRO [44], considered one
of the most responsive shoulder PROs [45–48], with a
minimal clinical important difference (MCID) of 8 to 13
points [45, 48] and a high standardised response mean
of 1.38. The SPADI is easy and fast to complete [48]
and, in a recent systematic review [49], it was
highlighted as one of three PROs for patients with rota-
tor cuff disease for which the psychometric properties
are supported by most strong or moderate evidence.
Baseline values for the primary outcome will be col-
lected from patient records, and passed on by the treat-
ing physician to the primary investigator, as completion
of the SPADI questionnaire is an integral part of the
medical examination. Primary outcome data will be fur-
ther collected at follow-up weeks 5, 10 and 16, with the
main analysis conducted for changes from baseline to 16
weeks follow-up, reported as the difference in mean
change between groups.
Secondary outcomes
Secondary outcome data will be collected at one or more
of the time-points (1) baseline assessment, (2) 5 weeks
follow-up, (3) 10 weeks follow-up and (4) 16 weeks
follow-up. See participant timeline in the SPIRIT dia-
gram (Fig. 1) for further details.
For the following secondary outcomes, the main ana-
lysis will be conducted for changes from baseline to 16
weeks follow-up, reported as the difference in mean
change between groups.
 Maximum isometric voluntary contraction (MVC)
in abduction and external rotation measured
using a handheld dynamometer in neutral
position (torque in Newton meter per kilo body
weight, Nm/kg). Measures of strength relate
directly to the intervention.
 Range of movement (ROM) in active shoulder
abduction (0 to 180°), measured using a digital
inclinometer, a widely used measure of function in
patients with SIS.
 An average of least pain and average pain
experienced during the last week (Numeric Rating
Scale: 0–10), a valid and reliable measure of pain
[50]. A measure of pain is important, as pain is one
of the cardinal complaints associated with SIS [51].
 Pain catastrophizing (score from 0 to 52), being
exaggerated negative thoughts related to
experienced or anticipated pain, which might be a
risk factor for chronicity [52], measured using the
Danish version of the Pain Catastrophizing Scale.
 Health-related Quality of Life index (EQ-5D-index,
range −0.167 to 1.00) measured with the EQ-5D-3 L [53].
 Health-related Quality of Life Visual Analogue Scale
(EQ-5D visual analogue scale, score 0–100, 0 =
lowest health-related quality of life) measured with
the EQ-5D-3 L [53].
For the following secondary outcomes, the main ana-
lysis will be conducted for the outcome at 16 weeks
follow-up, reported as the difference between groups at
16 weeks follow-up.
 Temporal Summation of Pain (TSP), a measure of
central excitability (range 0 to 10 cm on electronic
Visual analogue scale). A higher degree of TSP has
previously been found in patients with unilateral SIS
compared to healthy controls [54], and the decrease
in TSP after surgical intervention is reported to be
associated with the outcome of surgery [26].
 Conditioned Pain Modulation (CPM), a measure of
the attenuated pain response (increase in tolerated
pressure) to a painful pressure stimulus during
application of another painful pressure stimulus [55].
CPM is a proxy measure of the function of the
endogenous analgesia system, and patients with SIS
have a lower CPM compared to healthy controls [54].
 Pressure Pain Threshold (PPT) is a measure of local
mechanical hyperalgesia. It measures how much
mechanical pressure is needed to elicit the first onset
of pain. PPT is measured in kPa as the threshold for
first detection of pain. Patients with SIS have lower
PPTs in the shoulder region when compared to
matched controls, possibly indicating peripheral
sensitisation of the nervous system [26].
 Scapular Dysfunction (yes/no), measured using the
modified Scapula Assistance Test, assessing if
scapula muscle dysfunction influences the shoulder
disorder. The result of the modified Scapula
Assistance Test is a judgement of either positive
or negative.
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 Scapula Dyskinesia (yes/no), measured using the
Scapula Dyskinesis Test, the result of which is a
judgment of either positive or negative test.
 Global Impression of Change, measured on a 7-
point Likert scale ranging from ‘Much better, a
very important improvement’ to ‘Much worse, an
important aggravation’.
 Patient Acceptable Symptom State, measured as the
dichotomous answer (yes/no) to a standardised
question regarding the acceptability of the current
state of the shoulder symptoms.
Other outcomes of interest will be pain during testing
of external rotation MVC, abduction MVC and active
abduction ROM, as reported by the participant on a nu-
meric pain rating scale (0 to 10, 0 = no pain), using stan-
dardised verbal anchors for the instruction [50].
Sample size
The sample size estimation is based on the primary out-
come SPADI. Studies on patients with SIS have shown
standard deviations (SD) for SPADI change score after
11–12 weeks of between 17 [12] and 18.5 [56], while
longer durations seem to entail larger SDs, with a SD of
22 reported for SPADI change from 0 to 22 weeks [12].
The latter is similar to our own unpublished data from
SIS patients, showing a SD of 22.5 for SPADI change
from 0 to 6 months. Based on this previous data, we ex-
pect a common SD of 19.5 for SPADI change values
from week 0 to 16, the primary outcome. For the pur-
pose of this study, the MCID for SPADI will be consid-
ered to be 10 points, based on previous studies [45, 48].
The negative effect that any dropouts will have on the
statistical power will, to some degree, be reduced by the
use of multiple imputation. However, the imputation of
data will not fully redeem this, as multiple imputation
can cause an underestimation of the effect and a larger
variation in outcomes. Therefore, we aim at having a
high power of 95% to verify an effect equal to or higher
than the MCID of 10 points on SPADI, at a 5% signifi-
cance level. To obtain this, a total of 200 patients will be
required (100 in each group). This corresponds to a
Fig. 1 Summary of measures to be collected (SPIRIT figure)
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power of 89.7% in case of a 20% dropout and a power of
85.4% in case of a 40% dropout.
Recruitment strategies
All participants will be recruited consecutively from the
arthroscopic centre at the orthopaedic department, Hvi-
dovre Hospital immediately after undergoing clinical
examination performed by an orthopaedic specialist,
who will also make the initial eligibility screening and
provide written information about the trial for eligible
patients. In order to achieve adequate enrolment, the
orthopaedic specialists, who are at the first line of re-
cruitment, will be informed about the progress of the
trial at regular formal and informal meetings.
Procedures and data collection methods
At baseline, after written consent is signed and before
randomisation, all baseline assessments (Fig. 1) will be
conducted by clinical physiotherapists who are trained
in all assessment procedures and mutually aligned in
order to improve the quality of data. All post-allocation
assessments (week 5, 10 and 16) will be performed by
the same group of testers in order to secure consensus
regarding the instructions in questionnaires and conduc-
tion of tests. Participants will be instructed not to take
any pain medication during the 8 hours prior to any as-
sessment. Outcome assessors will also be trained in
counselling for adherence to follow-up testing (to facili-
tate retention) and avoidance of disclosing allocation in
a uniform manner. The study instruments are all de-
scribed in detail in Additional file 7.
In general, once a participant is enrolled, every reason-
able effort will be made to collect all outcomes for that
participant, regardless of any deviations from the inter-
vention protocol. Participants will receive text-message
reminders for all scheduled follow-up appointments.
The weekly text-messages with standardised questions
regarding exercise time will also ensure that participants
keep in mind their participation in the study. If partici-
pants do not attend their scheduled follow-up assess-
ment, they will be contacted and offered to re-schedule
to another date. If a participant should withdraw consent
to follow-up assessments, the participant is offered the
option to continue with the assessment of PROs.
Reasons for non-adherence to add-on intervention will
be recorded by the investigator providing the interven-
tion, either at the intervention visits or by phone if the
participant does not come to the scheduled appoint-
ment. Reasons for non-retention will be recorded by the
outcome assessor if this participant withdraws during a
follow-up session, or by the primary investigator in a
telephone interview.
Data management
All patient-reported questionnaires (SPADI, Pain Cata-
strophizing Scale, EQ-5D-5 L, Baseline and End of treat-
ment) will be filled in by the patient in a paper format,
and all data from the physiological measurements and
clinical tests will be entered in a paper Case Report
Form. Subsequently, all data will be entered in EpiData
(version 3.1 or newer) by study personnel, using blinded
double data entry to ensure data quality. The data entry
form will support valid values and range checks where
applicable. The original forms will be kept on file at a se-
cure location on the study site for a period of 3 years
after completion of the study. Data collected through
SMS-track is entered directly by the participant as they
send the answer in a text-message. The validity of data
will be secured through answer validation, where an-
swers that do not fit the specified requirements will be
rejected. Reminder messages will be automatically gener-
ated in case of missing answers.
All data from the BandCizer units will be stored on
the unit and transferred the BandCizer Backend Soft-
ware (BandCizer®, Denmark) via Bluetooth connection to
a dedicated repeater unit with internet access. All elec-
tronically entered data will be stored on a secure drive
at the study site.
No data monitoring committee will be composed and
no formal stopping guidelines and corresponding in-
terim analyses are planned. No other interim analyses
are planned.
Allocation
Participants will be randomly assigned to either the con-
trol or intervention group (CG or IG) at a 1:1 allocation
ratio, using a computer generated randomisation sched-
ule of permuted blocks of random sizes ranging from 4
to 10.
Participants will be randomised using sequentially
numbered, opaque, sealed envelopes. Investigators taking
part in allocation and data collection will be blinded to
block sizes and randomisation sequence at all times dur-
ing the study period. Allocation concealment will be en-
sured, as the envelopes will not be opened before the
participant has been irreversibly included in the study.
The creation of the randomisation schedule of permuted
blocks of random sizes, and subsequent packaging of se-
quentially numbered, opaque, sealed envelopes will be
performed by persons not else involved in the trial.
The final enrolment and subsequent allocation of par-
ticipants will be conducted by investigators not taking
part in any outcome assessment, who will be blinded to
the randomisation sequence at all times during the inter-
vention period. Outcome assessors will not take part in
any of the processes related to allocation.
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Blinding
Outcome assessors performing the outcome assessment
at baseline and follow-up weeks 5, 10 and 16 will be
blinded to group allocation. Given the nature of the
intervention, which requires the treating therapist to
know the intervention, blinding of intervention pro-
viders is not deemed feasible, and therefore will not be
performed. In order to obtain valid results from this
trial, intervention receivers will be kept blind to treat-
ment allocation. This will be attained through minimal
information about the content of the add-on interven-
tion and control condition until group allocation is final.
Accordingly, participants will be informed (written and
orally) that the study compares two different treatment
regimens, and that both include the treatment elements
normally offered, and adhere to the clinical guideline.
Additionally, study participant will be strongly incul-
cated not to enclose or discuss treatment allocation with
the outcome assessors, medical doctors or physiothera-
pists providing usual care.
All pre-defined analyses will be performed by a data
analyst blinded to allocation.
Emergency unblinding
Investigators and caregivers will be encouraged to con-
sult with the Medical Advisor (PH) in a case where
unblinding seems relevant. As the intervention is only
an add-on to usual care, and it will be modified with re-
spect to the participants pain response, the probability
of circumstances occurring where unblinding could be
relevant seem very slim.
Statistical methods – outcomes
For the primary end-point, namely SPADI score after 16
weeks, and for all continuous secondary outcomes listed
in Table 2, a constrained linear mixed model (cLMM)
will be applied in order to compare the change from
baseline to 16 weeks in the IG to that in the CG. The
model will contain the outcome at 16 weeks as the
dependent variable, treatment group (IG or CG) as the
main effect and both baseline score and any additional
follow-up measurements as repeated measurements, to
estimate the differences in mean change between groups
and corresponding 95% confidence intervals (95% CI)
(Table 3). The covariance structures will be selected
based on the MAICE procedure [57].
Mean scores and corresponding 95% CIs will be re-
ported for all outcome time-points (t0, t1, t2 and t3)
(Table 3). Within group changes between all outcomes
assessment time-points (t0-t1, t1-t2 and t2-t3), and be-
tween baseline and last assessment (t0 and t3), and cor-
responding 95% CI, will be reported (Table 4). Finally,
differences in within group changes between all out-
comes assessment time-points (t0-t1, t1-t2 and t2-t3) and
the corresponding 95% CIs will be reported (Table 5).
Results from the repeated measures analysis with SPADI
score as outcome will be visualised as illustrated in Fig. 2.
For comparison of binary outcomes, proportions will
be compared using a χ2 test, and odds ratio estimates
and corresponding 95% CIs will be reported.
Results from analyses comparing IG and CG for all
primary and secondary outcomes will be reported in the
second paper outlined in the ‘Dissemination policy’ sec-
tion, except for the results on secondary outcomes re-
garding pain sensitisation and scapula dyskinesia, which
will be reported in the third and fourth paper outlined
in the ‘Dissemination policy’ section, respectively.
P values will be reported to the fourth decimal. For all
tests, a two-sided significance level of ≤ 0.05 will be ap-
plied. All analyses will be conducted using up-to-date
versions of SPSS and SAS.
Statistical methods – additional analyses
Subgroup analyses For the outcomes SPADI score, ab-
duction MVC and external rotation MVC, subgroup
analyses investigating the modifying effect of scapula
dysfunction, scapula dyskinesia, temporal summation of
pain, conditioned pain modulation, pain pressure thresh-
old (site 1) and pain catastrophizing, respectively, will be
conducted. These will be performed using a cLMM,
similar to the corresponding main analyses, but includ-
ing a dichotomised value for the first measurement of
the relevant variable as the interaction term and report-
ing the effect estimates for each subgroup.
The following sensitivity analyses will be performed
for the primary outcome and reported together with the
primary analyses in the primary trial report:
 A per protocol analysis, similar to the primary
analysis, will be performed. From the IG, only
patients who attended intervention appointments on
weeks 0, 5 and 10 will be included in this analysis,
while all patients in the CG will be included.
 Adjusted cLMM to adjust the effect of treatment
allocation on SPADI score for any baseline
differences between groups. Baseline variables will
be included as covariates if (1) the difference
between groups is more than 0.3 of the common SD
for continuous outcomes, or (2) proportions are
significantly different (P < 0.05) between groups, for
binary outcomes.
 Sensitivity analyses to investigate the importance of
the clinometric properties of the SPADI score may
be relevant. This is based on a very recent study
[58], which evaluates the SPADI score using the
Rasch model. The study was published after
initiation of this trial.
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Three exploratory dose-response analyses will be per-
formed. Only participants in the IG will be included in
these analyses. First, the interacting effect of adherence
to the intervention, TSP and CPM, on change in exter-
nal rotation MVC, abduction MVC and SPADI score
(outcomes), will be investigated. Secondly, whether the
effect of TSP and CPM is mediated by adherence to the
intervention will also be assessed. These analyses will be
conducted as available-case analyses.
For all included variables, data from each time-period
(t0-t1, t1-t2 and t2-t3) will be included as repeated mea-
surements in these analyses. The outcome variable is the
change between first and last measurement in a time-
period. ‘Adherence’ to the intervention is the total TUT
in a time-period. ‘Central Pain Sensitization’ score (TSP
or CPM) is the score from the last time-point in each
time-period.
Additionally, results will also be presented for similar
analyses adjusted for Usual Care, calculated for each
time-period as the average of time spent on usual care,
as reported by text-message, in all weeks included in the
relevant time-period.
Statistical methods – analysis population and missing data
All main analyses will be conducted as intention-to-treat
analyses, including all randomised participants, regard-
less of protocol adherence. Participants will be analysed
as randomised. To create a full analysis dataset for the
Table 2 Variables, outcome measures and methods of analysis
Variable/outcome Hypothesis Outcome measure Methods of analysis
Primary outcome Intervention improved outcome
SPADI change Δt0-t3 Score 0–100 (continuous) cLMM
Secondary outcomes Intervention improved outcome
Abd. MVC change Δt0-t3 Nm/kg (continuous) cLMM
Ext. rot. MVC change Δt0-t3 Nm/kg (continuous) cLMM
Abd. total ROM change Δt0-t3 Degrees (continuous) cLMM
Pain last week change Δt0-t3 NRS 0–10 (continuous) cLMM
EQ-5D change Δt0-t3 Index value (continuous) cLMM
Global impression of change, at t3 % much improved/fully
recovered (binary)
χ2 test
Pain sensitisation Δt1-t3
Temporal Summation of Pain VAS increase (continuous) cLMM
Conditioned Pain Modulation kPa increase (continuous) cLMM
Pain Pressure Threshold kPa (continuous) cLMM
Scapular involvement
SAT % positive (binary) χ2 test
SDT % positive (binary) χ2 test
Subgroup analyses
Scapula involvement
(SAT and SDT yes/no)
Dysfunction modifies the effect
of intervention
SPADI score, abduction MVC and
external rotation MVC (continuous)
cLMM with
interaction term
Central sensitisation
(TS and CPM high vs. low)
CS modifies the effect of intervention SPADI score, abduction MVC and
external rotation MVC (continuous)
cLMM with
interaction term
Sensitivity analyses Intervention improved outcome Primary outcome
Per protocol analysis cLMM
Adjusting for baseline cLMM
cLMM constrained linear mixed model, EQ-5D EuroQol 5D-3 L, MVC maximum voluntary contraction, Nm/kg Newton meter per kilo body weight, ROM range of
movement, SAT scapula dysfunction, SDT scapula dyskinesia, SPADI Shoulder Pain and Disability Index, VAS visual analogue scale
Table 3 Outcomes (Mean, SD)
Week 0 Week 5 Week 10 Week 16
IG CG IG CG IG CG IG CG
SPADI score
Abduction MVC
External rotation MVC
Abduction ROM
Pain last week
QoL (EQ-5D)
CG control group, IG intervention group, MVC maximum voluntary contraction,
QoL quality of life, ROM range of movement, SPADI Shoulder Pain and
Disability Index
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intention-to-treat analyses, missing outcome data will be
imputed using multiple imputations based on the vari-
ables of all previous scores in the relevant outcome, age,
sex and allocation.
Harms
Adverse events will be defined in this context as any un-
intended, unfavourable findings, symptom or illnesses
that occur during the assessment or the add-on inter-
vention, whether it can be attributed to the assessment
or not. Adverse events will be recorded in part by the
patient as a spontaneous recording during assessment
and by open questioning.
Acute exacerbations of shoulder symptoms will be re-
corded by the primary investigator (MC) and, as a safety
precaution, in case a medical evaluation is required, the
participant will be referred to the Medical Advisor (PH).
Patients in the intervention group experiencing exacer-
bations lasting more than 1 week will be referred to the
Medical Advisor (PH) and evaluated if further medical
care is needed.
Serious unexpected side effects or serious adverse
events will be reported to the Capital Regional Ethics
Committee in Denmark within 7 days after sponsor or
the primary investigator has become aware of the inci-
dent. Serious adverse events will be categorised accord-
ing to the definitions established by the United States
Food and Drug Administration [59] and will be assessed
by the primary investigator for possible relations with
the assessment and/or intervention to consider whether
there is a reasonable possibility that the adverse event
can be caused by either.
No audits are planned.
Dissemination policy
All results from the study, be they positive, negative or
inconclusive, will be published in international scientific
journals. The project leader will enforce publication.
Furthermore, the results will be presented at national
and international conferences. Working titles for scien-
tific publications are listed below. In the primary trial re-
port, all collected outcomes will be defined and
referenced to the dissemination plan below if data or
analyses are not reported in the primary trial report.
1. The Strengthening Exercises in Shoulder
Impingement trial (The SExSI-Trial): Protocol for a
pragmatic, assessor blinded, parallel-group, rando-
mised, controlled, superiority trial investigating the
effectiveness of adding a simple shoulder
strengthening exercise programme to usual care,
in patients with long-lasting subacromial im-
pingement syndrome.
2. The effectiveness of adding to usual care a simple
programme of Strengthening Exercises In Subacromial
Impingement patients (The SExSI-Trial): A randomised
controlled trial (Primary trial report focusing on the
primary outcome and analysis, as well as supportive
secondary analyses for the primary outcome).
3. The dose-response relationship between adherence
to the intervention and changes in shoulder strength
and patient-reported shoulder function: Pre-defined
secondary analyses from the SExSI-Trial.
Table 4 Within group change scores (95% CI)
Week 0–5 Week 5–10 Week 10–16 Week 0–16
IG CG IG CG IG CG IG CG
SPADI score
Abduction MVC
External rotation MVC
Abduction ROM
Pain last week
QoL (EQ-5D)
CG control group, IG intervention group, MVC maximum voluntary contraction, QoL quality of life, ROM range of movement, SPADI Shoulder Pain and
Disability Index
Table 5 Between group difference in change scores (95% CI)
Week 0 to
5
(95% CI)
Week 5 to
10
(95% CI)
Week 10 to
16
(95% CI)
Week 0 to
16
(95% CI)
SPADI score
Abduction MVC
External rotation
MVC
Abduction ROM
Pain last week
QoL (EQ-5D)
CG control group, IG intervention group, MVC maximum voluntary contraction,
QoL quality of life, ROM range of movement, SPADI Shoulder Pain and
Disability Index
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4. The effectiveness of the SExSI-Trial add-on
intervention on pain sensitisation, the modifying
effect pain sensitisation on treatment outcomes
and mediating effects of pain sensitisation on the
dose-response relationship between intervention
adherence and changes in outcomes: Pre-defined
secondary analyses from the SExSI-Trial.
5. The modifying effect of scapula dysfunction at
baseline on shoulder strength and function
outcomes and the effectiveness of the add-on inter-
vention on scapula dysfunction: Pre-defined second-
ary analyses from the SExSI-Trial.
Additionally, the results of this study will be commu-
nicated directly to the participants, who will be encour-
aged to comment on disseminated trial results in order
to improve their further public dissemination. Further-
more, trial results will be disseminated to the public in
general through the daily press.
Dissemination policy – authorship
Decisions on authorship eligibility will adhere to the
Harvard author guideline statement as endorsed by the
Faculty Council of Harvard Medical School (https://
hms.harvard.edu/sites/default/files/assets/Sites/Ombuds/
files/AUTHORSHIP%20GUIDELINES.pdf).
Topics suggested for presentation and/or publication,
including suggestion and justification for authors to be
reviewed for the Writing Committee, will be presented
to the members of the Steering Committee. The Steering
Committee will form the Writing Committee and decide
on author sequence. Disputes regarding authorship will
be settled by the Primary investigator after consulting
with the Supervising investigator.
Discussion
This trial (the SExSI-Trial) will investigate the effective-
ness of adding a simple shoulder strengthening exercise
programme to usual care in patients with long-lasting
SIS. If the intervention is found effective in improving
patient-reported shoulder function, the intervention will
be easily implemented as an addition to usual care.
The current trial is planned and designed to maximise
the usefulness of the trial results by focusing on features
that have recently been suggested as important when
considering the usefulness of clinical research [60]. We
further believe that the research question raised in
this trial satisfies the FINER-criteria [61], as it is con-
sidered both Feasible, Interesting, Novel, Ethical and
Relevant (Table 6).
Firstly, the ‘problem base’ and ‘context placement’ have
been described in the Background section. Accordingly,
the treatment of shoulder impingement syndrome is a
problem that is worthwhile to address, based on the ex-
tent of the problem and the substantial societal costs re-
lated to the disorder. Furthermore, the systematic
literature review, as is presented in the Background sec-
tion, clearly indicates that knowledge is lacking with
regards to the effect of strengthening exercises in the re-
habilitation of patients with long-lasting SIS. The SExSI-
Trial will provide relevant insight into this area, contrib-
uting to fill this gap.
Secondly, a focus on information gain, pragmatism
and patient centeredness is secured through methodo-
logical considerations. The trial has been accordingly de-
signed to optimise the information gained from the
study by implementing multiple follow-up time-points
and a close monitoring of intervention adherence. This
makes it possible to conduct relevant dose-response ana-
lyses, which in turn will guide future research. The prag-
matism of the trial is improved by the use of broad
eligibility criteria, a consecutive sampling strategy and
usual care as the comparator, aspects that will improve
the generalisability of the trial results. Moreover, the
choice of SPADI as the primary outcome is in line with
the fact that pain and loss of function are the main com-
plaints associated with SIS [51]. This improves the pa-
tient centeredness of the trial, as the goal of the
intervention is meaningful to the patients.
Finally, the pre-registration at clinicaltrials.gov and publi-
cation of this trial protocol, including intervention descrip-
tions based on the TIDieR framework [33], greatly improves
the transparency of the trial conduct and results. Collect-
ively, all of these efforts are likely to improve the usefulness
of the trial results, and hence the relevance of the trial itself.
Fig. 2 Visualisation of changes in SPADI score in the intervention
and control group, respectively (example, not based on data)
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Strengths and limitations
Aside from the above, this trial has some methodological
strengths and limitations which must be taken into ac-
count when interpreting the study findings.
Strengths
The blinding of participants, data analysts, outcome as-
sessor and usual care providers greatly decreases the risk
of bias in the current trial, supporting the internal valid-
ity of study findings. The external validity is further im-
proved by the use of consecutive sampling, thereby
improving the generalisability of the results.
Limitations
Given the nature of the intervention, the intervention
providers could not be blinded, which increases the risk
of bias in the trial. Furthermore, the use of a single
centre study design, and the fact that the intervention is
provided in a setting outside the normal usual care, de-
creases the external validity of the study, as study find-
ings might not be generalisable to other settings. It is
not within the scope of this study to conduct cost-
effectiveness analyses or to conduct qualitative work to
evaluate patient acceptability and experience of the
home-based exercise programme. While the objective
monitoring of adherence will show to what degree
patients have accepted and managed to perform the
intervention as prescribed, qualitative work could be
conducted in order to investigate patient experiences
with the intervention and reasons for adherence and
non-adherence in order to improve implementation of
the intervention. Cost-effectiveness analyses could also
be performed in order to inform policy-makers and
support implementation. The current study will,
nevertheless, provide level-one evidence regarding the
effectiveness of the add-on intervention.
Trial status
Protocol version
Issue date: 10 May 2017, Protocol amendment 01,
Author MC.
Revision chronology
Version 1, 25.02.2016 Original.
Version 2, 10.05.2017 Amendment 1. Primary reason
for amendment: EQ-5D-3 L was added as outcome at 1-
year follow-up.
Recruitment
Recruitment was initiated May 1, 2016, and is expected
to be finalised April 1, 2018.
Additional files
Additional file 1: Populated SPIRIT checklist (PDF 172 kb)
Additional file 2: TIDieR control, usual care. (PDF 113 kb)
Additional file 3: TIDieR intervention, strengthen your shoulder. (PDF 207 kb)
Additional file 4: Strengthen your shoulder, intervention leaflet 1.
(PDF 411 kb)
Additional file 5: Strengthen your shoulder, intervention leaflet 2.
(PDF 557 kb)
Additional file 6: Strengthen your shoulder, intervention leaflet 3.
(PDF 588 kb)
Additional file 7: Data collection methods – study instruments.
(PDF 235 kb)
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At the end of the medical examination, the treating orthopaedic specialist or
the cooperating nurse will introduce the trial to patients fulfilling the
eligibility criteria. Patients will be informed about the request for
participation in the trial, and will be provided with participant information
and a brochure on test subject’s rights. As soon as possible thereafter,
patients will be contacted by one of the investigators. A final eligibility
screening will be conducted and eligible patients will be offered a meeting
to provide oral information about the trial, their rights as test subjects and
the possibility to ask clarifying questions. Patients are offered deliberation
time before being asked to sign written consent forms regarding willingness
to participate.
Consent or assent – ancillary studies
In the oral information and in the participant information sheets, patients will be
informed that a 1 year follow-up is planned for all participants, and that this is
covered by the written consent forms. Data for the 1 year follow-up will, in part, be
collected through text messages, using the SMS-track© (data hosted at a BFIH
certified data centre that meets the ISO 27002 standards). Through
answers to auto-generated standardized SMS questions, patients will be asked to
report sick leave due to their shoulder disorder (weekly). Questions regarding surgery,
if any, for SIS (yearly), the EQ-5D-3 L questionnaire (yearly), and all
questions from the SPADI questionnaire (after 6 months and 1 year) will be
administered using the REDCap® system.
Confidentiality
All study-related information on participants will be stored securely on the
study site. All completed paper forms will be stored in locked file cabinets
before and after data is entered to an electronic database. All electronic
participants’ information will be stored on a secured study-specific drive at
the study site. Access to the study-specific drive will be limited to users
currently working on the project and therefore need access to the secured
drive in order to store and/or analyse data. Access will be limited by
individual person-specific login and passwords. A list of persons with access
to the study-specific drive will be kept up-to-date by the primary
investigator. Appointment schedules and any other listings that link
participant to other identifying information will be stored separately in the
hospital’s secured intranet system or in separate locked file cabinets in an
area with limited access. Study information will not be released outside of
the study without the permission of the relevant participant. The study will
be reported to and approved by the Danish Data Protection Agency before
start of inclusion, and will adhere to the “Act on Processing Personal Data”.
Ancillary and post-trial care
In general, no ancillary or post-trial care is provided to participants in the
trial. However, the details of the intervention will be made public shortly
after the trial is over, and the intervention could therefore be replicated by
physiotherapists in ordinary settings.
Consent for publication
Written informed consent for publication of images in the intervention
leaflet was obtained from the person appearing on the pictures. A copy of
the consent form is available for review by the Editor of this journal.
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